International Flavors & Fragrances SG&A decreased by 9.0% to $427.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 7.4%, from $461.00M to $427.00M. Over 4 years (FY 2021 to FY 2025), SG&A shows relatively stable performance with a 1.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A rising ratio of SG&A to revenue may indicate inefficiency or aggressive expansion, while a falling ratio suggests improved operating leverage.
Selling, general, and administrative expenses encompass the costs associated with the day-to-day operation of the busine...
Standard operating expense category; peers with larger global sales forces typically show higher absolute SG&A levels.
selling_general_and_administrative| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $412.00M | $436.00M | $450.00M | $459.00M | $456.00M | $413.00M | $440.00M | $454.00M | $445.00M | $444.00M | $444.00M | $490.00M | $493.00M | $495.00M | $517.00M | $461.00M | $483.00M | $421.00M | $469.00M | $427.00M |
| QoQ Change | — | +5.8% | +3.2% | +2.0% | -0.7% | -9.4% | +6.5% | +3.2% | -2.0% | -0.2% | +0.0% | +10.4% | +0.6% | +0.4% | +4.4% | -10.8% | +4.8% | -12.8% | +11.4% | -9.0% |
| YoY Change | — | — | — | — | +10.7% | -5.3% | -2.2% | -1.1% | -2.4% | +7.5% | +0.9% | +7.9% | +10.8% | +11.5% | +16.4% | -5.9% | -2.0% | -14.9% | -9.3% | -7.4% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Taste | — | — | — | $94.00M | $98.00M | $103.00M | $101.00M | $101.00M |
| Food Ingredients | — | — | — | $92.00M | $104.00M | $104.00M | $100.00M | $99.00M |
| Scent | $93.00M | $94.00M | $101.00M | $86.00M | $92.00M | $97.00M | $91.00M | $92.00M |
| Health & Biosciences | $89.00M | $96.00M | — | $81.00M | $91.00M | $87.00M | — | — |
| Nourish | $219.50M | $219.50M | $219.50M | — | — | — | — | — |
| Pharma Solutions | $26.00M | $30.00M | $31.00M | $32.00M | $10.00M | — | — | — |
| Total | $493.00M | $495.00M | $517.00M | $461.00M | $483.00M | $421.00M | $469.00M | $427.00M |
Nourish is derived from annual filings.
Nourish, Pharma Solutions were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.